Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA)

Background: Activated phosphoinositide 3-kinase (PI3K) δ Syndrome (APDS) is an ultra-rare, potentially life-threatening disease that lacks approved treatments in Spain. This study aimed to apply Multi-Criteria Decision Analysis (MCDA) to assess the value of the first pharmacological treatment for AP...

Descripción completa

Detalles Bibliográficos

Autores principales:	María Reyes Abad, Carmen Alerany, Luis Ignacio Gonzalez, Olaf Neth, Concepción Payares-Herrera, Carlos Rodríguez-Gallego, Jose Luis Trillo, Kirsten H. Herrmann, Raquel Figueiredo, Alicia Gil
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	AboutScience Srl 2025-01-01
Colección:	Global & Regional Health Technology Assessment
Materias:	Activated phosphoinositide 3-kinase (PI3K) δ Syndrome (APDS) Decision-making Multi-criteria Decision Analysis (MCDA) Ultra-rare disease, leniolisib
Acceso en línea:	https://journals.aboutscience.eu/index.php/grhta/article/view/3199
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!